Plasma steroid metabolome profiling for the diagnosis of adrenocortical carcinoma S Schweitzer, M Kunz, M Kurlbaum, J Vey, S Kendl, T Deutschbein, ... European journal of endocrinology 180 (2), 117-125, 2019 | 79 | 2019 |
Plasma protein binding of polyphenols from maritime pine bark extract (USP) M Kurlbaum, P Högger Journal of pharmaceutical and biomedical analysis 54 (1), 127-132, 2011 | 73 | 2011 |
Reference intervals for LC-MS/MS measurements of plasma free, urinary free and urinary acid-hydrolyzed deconjugated normetanephrine, metanephrine and methoxytyramine G Eisenhofer, M Peitzsch, D Kaden, K Langton, A Mangelis, C Pamporaki, ... Clinica chimica acta 490, 46-54, 2019 | 71 | 2019 |
Objective response and prolonged disease control of advanced adrenocortical carcinoma with cabozantinib M Kroiss, F Megerle, M Kurlbaum, S Zimmermann, J Wendler, C Jimenez, ... The Journal of Clinical Endocrinology & Metabolism 105 (5), 1461-1468, 2020 | 66 | 2020 |
The saline infusion test for primary aldosteronism: implications of immunoassay inaccuracy G Eisenhofer, M Kurlbaum, M Peitzsch, G Constantinescu, H Remde, ... The Journal of Clinical Endocrinology & Metabolism 107 (5), e2027-e2036, 2022 | 47 | 2022 |
Facilitated uptake of a bioactive metabolite of maritime pine bark extract (Pycnogenol) into human erythrocytes M Kurlbaum, M Mülek, P Högger PloS one 8 (4), e63197, 2013 | 35 | 2013 |
Development and validation of a sensitive liquid chromatography tandem mass spectrometry assay for the simultaneous determination of ten kinase inhibitors in human serum and plasma F Aghai, S Zimmermann, M Kurlbaum, P Jung, T Pelzer, H Klinker, ... Analytical and Bioanalytical Chemistry 413, 599-612, 2021 | 34 | 2021 |
Population pharmacokinetics and target attainment of meropenem in plasma and tissue of morbidly obese patients after laparoscopic intraperitoneal surgery M Wittau, J Scheele, M Kurlbaum, C Brockschmidt, AM Wolf, E Hemper, ... Antimicrobial agents and chemotherapy 59 (10), 6241-6247, 2015 | 30 | 2015 |
Metabolic impact of pheochromocytoma/paraganglioma: targeted metabolomics in patients before and after tumor removal Z Erlic, M Kurlbaum, T Deutschbein, S Nölting, A Prejbisz, H Timmers, ... European journal of endocrinology 181 (6), 647-657, 2019 | 27 | 2019 |
Steroidogenesis in the NCI-H295 cell line model is strongly affected by culture conditions and substrain M Kurlbaum, S Sbiera, S Kendl, MM Fassnacht, M Kroiss Experimental and Clinical Endocrinology & Diabetes 128 (10), 672-680, 2020 | 26 | 2020 |
Method-specific cortisol and dexamethasone thresholds increase clinical specificity of the dexamethasone suppression test for Cushing syndrome N Vogg, M Kurlbaum, T Deutschbein, B Gräsl, M Fassnacht, M Kroiss Clinical Chemistry 67 (7), 998-1007, 2021 | 23 | 2021 |
Harmonization of LC-MS/MS measurements of plasma free normetanephrine, metanephrine, and 3-methoxytyramine M Peitzsch, T Novos, D Kaden, M Kurlbaum, AE van Herwaarden, ... Clinical Chemistry 67 (8), 1098-1112, 2021 | 22 | 2021 |
A method for the minimally invasive drug monitoring of mitotane by means of volumetric absorptive microsampling for a home-based therapeutic drug monitoring B Friedl, M Kurlbaum, M Kroiss, M Fassnacht, O Scherf-Clavel Analytical and bioanalytical chemistry 411, 3951-3962, 2019 | 19 | 2019 |
Enzyme autoinduction by mitotane supported by population pharmacokinetic modeling in a large cohort of adrenocortical carcinoma patients U Arshad, M Taubert, M Kurlbaum, S Frechen, S Herterich, F Megerle, ... European journal of endocrinology 179 (5), 287-297, 2018 | 19 | 2018 |
Drug synergism of proteasome inhibitors and mitotane by complementary activation of ER stress in adrenocortical carcinoma cells M Kroiss, S Sbiera, S Kendl, M Kurlbaum, M Fassnacht Hormones and Cancer 7 (5), 345-355, 2016 | 18 | 2016 |
Population pharmacokinetics and target attainment of ertapenem in plasma and tissue assessed via microdialysis in morbidly obese patients after laparoscopic visceral surgery M Wittau, S Paschke, M Kurlbaum, J Scheele, NS Ly, E Hemper, ... Antimicrobial Agents and Chemotherapy 61 (1), 10.1128/aac. 00952-16, 2017 | 16 | 2017 |
Confirmatory testing of primary aldosteronism with saline infusion test and LC-MS/MS CT Fuss, K Brohm, M Kurlbaum, A Hannemann, S Kendl, M Fassnacht, ... European Journal of Endocrinology 184 (1), 167-178, 2021 | 15 | 2021 |
FSCN1 as a new druggable target in adrenocortical carcinoma C Ruggiero, M Tamburello, E Rossini, S Zini, N Durand, G Cantini, ... International Journal of Cancer 153 (1), 210-223, 2023 | 10 | 2023 |
Ruxolitinib exposure in patients with acute and chronic graft versus host disease in routine clinical practice—a prospective single-center trial N Isberner, S Kraus, GU Grigoleit, F Aghai, M Kurlbaum, S Zimmermann, ... Cancer Chemotherapy and Pharmacology 88, 973-983, 2021 | 10 | 2021 |
Plasma metabolome profiling for the diagnosis of catecholamine producing tumors J März, M Kurlbaum, O Roche-Lancaster, T Deutschbein, M Peitzsch, ... Frontiers in Endocrinology 12, 722656, 2021 | 9 | 2021 |